Abstract 2063P
Background
In this study we seek to learn more about the lifestyle habits of our cancer patients, with a particular emphasis in exercise and eating behaviours. We choose to focus on these two areas as they have an outsized impact on clinical outcomes such as mortality, risk of relapse, quality of life, sarcopenia, duration of hospitalizations, post-surgical complications, response to immunotherapy and even overall survival rates.
Methods
Observational study across a cross-section of cancer patients at the Medical Oncology Service of the Nuestra Señora de Candelaria University Hospital, Santa Cruz de Tenerife. The statistical significance of lifestyle habit changes is tested through a form and IPAQ, MUST, and SARC-F surveys using chi-squared tests.
Results
We involved 100 patients whose average age was 61 years. 46% of patients had lung cancer, 30% breast cancer and 10% gastrointestinal cancer. 59% patients had stage-four cancer, 48% were receiving first-line treatment and 54% were being treated with immunotherapy or target therapies. 99% of individuals considered their diet as an important pillar in their cancer disease. However, we found that only 47% had discussed aspects of their nutrition with their oncologist, but this was not statistically associated with a reduced risk of malnutrition. 80% considered that a healthy lifestyle could help reduce the adverse effects of the treatment. The validated test results showed that 45% had an intermediate-high risk of malnutrition according to the MUST test and 14% had risk of sarcopenia according to the SARC-F test. Patients receiving immunotherapy or target therapies had a higher risk of malnutrition than those receiving other treatments (50 vs 42%, p=.507). 47% were sedentary according to the IPAQ test and 80% who did not perform physical activity would start an adapted exercise program if it were available.
Conclusions
Our patients present good high-level awareness about the generally positive ways in which lifestyle changes involving healthier eating and exercise habits can impact the outcome of their treatments. However, we appreciate a need for more specific nutritional and fitness recommendations that patients can immediately put into practice, as well their ranked impact on their health.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2076P - Topical diclofenac for prevention of HFS in patients receiving capecitabine monotherapy: An exploratory subgroup analysis of the D-ToRCH phase III trial
Presenter: Akhil Santhosh
Session: Poster session 06
2077P - A randomized, placebo-controlled trial assessing the efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, B1, B2, B6, E, Mg, Zn and a fatty acid for 6 months in the management of chemotherapy induced neuropathic pain
Presenter: Triantafylos Didangelos
Session: Poster session 06
2078P - Evaluation of chemotherapy-induced nausea and vomiting beyond the delayed phase: Results of a survey of healthcare providers in Japan
Presenter: Florian Scotté
Session: Poster session 06
2079P - Naloxegol for the treatment of opioid-induced constipation in patients with cancer pain: A pooled analysis of real-world studies (NALOPOOL)
Presenter: Maria del Carmen Beato Zambrano
Session: Poster session 06
2080P - Incidence and risks of intravenous chemotherapy-induced neutropenia (ICIN) in oncology: A multicenter retrospective cohort study on real-life data
Presenter: Olivia Rohr
Session: Poster session 06
2081P - The therapeutic effect of anti-inflammatory tripeptide cream on hand-foot syndrome related to anticancer drugs: A prospective, randomized, placebo-controlled pilot trial
Presenter: Yaewon Yang
Session: Poster session 06
2082P - TASMAN: An international survey on the knowledge, aTtitudes and clinical pAtternsS of use of Medical Cannabis for caNcer care
Presenter: Marco Filetti
Session: Poster session 06
2083P - Association between VTE location and risk of recurrent, bleeding and death in the international prospective TESEO SEOM cancer cohort
Presenter: Rocío Martín Lozano
Session: Poster session 06
2084P - Cardiovascular (CV) mortality among metastatic cancer patients: A retrospective cohort study
Presenter: Irbaz Riaz
Session: Poster session 06
2085P - Buprenorphine use and cancer outcomes
Presenter: Nosayaba Osazuwa-Peters
Session: Poster session 06